Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Leukemia ; 33(5): 1219-1230, 2019 05.
Article in English | MEDLINE | ID: mdl-30353030

ABSTRACT

In the past years, the genomes of thousands of tumors have been elucidated. To date however, our knowledge on somatic gene alterations in normal cells is very limited. In this study, we demonstrate that tetanus-specific human memory B lymphocytes carry a substantial number of somatic mutations in the coding regions of the genome. Interestingly, we observed a statistically significant correlation between the number of exome mutations and those present in the immunoglobulin heavy variable regions. Our findings indicate that the majority of these genomic mutations arise in an antigen-dependent fashion, most likely during clonal expansion in germinal centers. The knowledge that normal B cells accumulate genomic alterations outside the immunoglobulin loci during development is relevant for our understanding of the process of lymphomagenesis.


Subject(s)
B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Immunologic Memory , Mutation , Clonal Selection, Antigen-Mediated , Humans , Immunoglobulin Heavy Chains/genetics , Tetanus/immunology , Exome Sequencing
3.
Leukemia ; 26(7): 1647-53, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22382892

ABSTRACT

Ocular adnexal marginal zone B-cell lymphomas (OAMZLs) arise in the connective tissues of the orbit or in the mucosa-associated lymphoid tissue of the conjunctiva. Here, we present the immunological and genetic analyses of 20 primary Chlamydia psittaci (Cp)-negative OAMZLs. Analysis of the immunoglobulin variable heavy chain (IgV(H)) gene usage demonstrated a significant preference for V(H)4-34. A combined analysis across all previously published OAMZLs confirmed that this is a general feature of OAMZL, in particular of the Cp-negative group. Our series of OAMZLs did not express the characteristic rheumatoid factor V(H)DJ(H) rearrangements that were previously found in salivary gland- and gastric-marginal zone B-cell lymphomas (MZBCLs). We did not detect the MZBCL-specific chromosomal translocations, t(11;18) API2-MALT1 (mucosa-associated lymphoid tissue1) and t(14;18) IgH/MALT1. Two cases contained a premature stop codon in the A20 gene (TNFAIP3) and one case harbored the activating MYD88 hotspot mutation L265P. Variable nuclear expression of BCL10, NFκB1 (p50) and NFκB2 (p52) suggests that other additional genetic abnormalities affecting the NFκB pathway exist within this group of lymphomas. OAMZL showed variable expression of the chemokine receptor CXCR3 and integrin α4ß7 by the tumor B cells, and low interferon-γ and interlukin-4 mRNA levels in the tissue, indicative of an inflammatory environment with features in between those previously found in cutaneous and other extranodal MZBCL. The strongly biased usage of V(H)4-34 in Cp-negative OAMZLs suggests involvement of a particular stimulatory (auto-) antigen in their development.


Subject(s)
Gene Rearrangement, B-Lymphocyte, Heavy Chain , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , Inflammation/metabolism , Lymphoma, B-Cell, Marginal Zone/genetics , Lymphoma, B-Cell, Marginal Zone/immunology , Blotting, Western , Cell Nucleus/metabolism , Chlamydophila psittaci/genetics , Chlamydophila psittaci/isolation & purification , DNA, Bacterial/genetics , Humans , Immunoenzyme Techniques , Inflammation/genetics , Inflammation/immunology , Interferon-gamma/genetics , Interferon-gamma/metabolism , Interleukin-4/genetics , Interleukin-4/metabolism , Lymphoma, B-Cell, Marginal Zone/microbiology , Mutation/genetics , NF-kappa B/genetics , NF-kappa B/metabolism , Prognosis , Psittacosis/genetics , Psittacosis/immunology , Psittacosis/microbiology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Translocation, Genetic
4.
Circulation ; 109(13): 1647-52, 2004 Apr 06.
Article in English | MEDLINE | ID: mdl-15023889

ABSTRACT

BACKGROUND: Arteriogenesis refers to the development of collateral conductance arteries and is orchestrated by circulating monocytes, which invade growing collateral arteries and act as suppliers of cytokines and growth factors. CD44 glycoproteins are involved in leukocyte extravasation but also in the regulation of growth factor activation, stability, and signaling. Here, we explored the role of CD44 during arteriogenesis. METHODS AND RESULTS: CD44 expression increases strongly during collateral artery growth in a murine hind-limb model of arteriogenesis. This CD44 expression is of great functional importance, because arteriogenesis is severely impaired in CD44-/- mice (wild-type, 54.5+/-14.9% versus CD44-/-, 24.1+/-9.2%, P<0.001). The defective arteriogenesis is accompanied by reduced leukocyte trafficking to sites of collateral artery growth (wild-type, 29+/-12% versus CD44-/-, 18+/-7% CD11b-positive cells/square, P<0.01) and reduced expression of fibroblast growth factor-2 and platelet-derived growth factor-B protein. Finally, in patients with single-vessel coronary artery disease, the maximal expression of CD44 on activated monocytes is reduced in case of impaired collateral artery formation (poor collateralization, 1764+/-572 versus good collateralization, 2817+/-1029 AU, P<0.05). CONCLUSIONS: For the first time, the pivotal role of CD44 during arteriogenesis is shown. The expression of CD44 increases during arteriogenesis, and the deficiency of CD44 severely impedes arteriogenesis. Maximal CD44 expression on isolated monocytes is decreased in patients with a poor collateralization compared with patients with a good collateralization.


Subject(s)
Chemotaxis, Leukocyte/physiology , Collateral Circulation/physiology , Hyaluronan Receptors/physiology , Aged , Animals , Collateral Circulation/genetics , Endothelium, Vascular/metabolism , Female , Femoral Artery , Fibroblast Growth Factor 2/biosynthesis , Fibroblast Growth Factor 2/genetics , Gene Expression Regulation , Hindlimb/blood supply , Humans , Hyaluronan Receptors/biosynthesis , Hyaluronan Receptors/genetics , Ischemia/physiopathology , Ligation , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , Proto-Oncogene Proteins c-sis/biosynthesis , Proto-Oncogene Proteins c-sis/genetics , Reverse Transcriptase Polymerase Chain Reaction , Specific Pathogen-Free Organisms
5.
Br J Cancer ; 90(1): 224-9, 2004 Jan 12.
Article in English | MEDLINE | ID: mdl-14710233

ABSTRACT

Nonsteroidal anti-inflammatory drugs (NSAIDs) have chemopreventive potential against colorectal carcinomas (CRCs). Inhibition of cyclooxygenase (COX)-2 underlies part of this effect, although COX-2-independent mechanisms may also exist. Nonsteroidal anti-inflammatory drugs appear to inhibit the initial stages of the adenoma-carcinoma sequence, suggesting a link to the APC/beta-catenin/TCF pathway (Wnt-signalling pathway). Therefore, the effect of the NSAID sulindac on nuclear (nonphosphorylated) beta-catenin and beta-catenin/TCF-mediated transcription was investigated. Nuclear beta-catenin expression was assessed in pretreatment colorectal adenomas and in adenomas after treatment with sulindac from five patients with familial adenomatous polyposis (FAP). Also, the effect of sulindac sulphide on beta-catenin/TCF-mediated transcription was studied. Adenomas of FAP patients collected after treatment with sulindac for up to 6 months showed less nuclear beta-catenin expression compared to pretreatment adenomas of the same patients. Sulindac sulphide abrogated beta-catenin/TCF-mediated transcription in the CRC cell lines DLD1 and SW480, and decreased the levels of nonphosphorylated beta-catenin. As a result, the protein levels of the positively regulated TCF targets Met and cyclin D1 were downregulated after sulindac treatment. This study provides in vivo and in vitro evidence that nuclear beta-catenin localisation and beta-catenin/TCF-regulated transcription of target genes can be inhibited by sulindac. The inhibition of Wnt-signalling provides an explanation for the COX-2-independent mechanism of chemoprevention by NSAIDs.


Subject(s)
Adenoma/genetics , Adenomatous Polyposis Coli/genetics , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cell Transformation, Neoplastic , Colorectal Neoplasms/genetics , Proto-Oncogene Proteins/physiology , Sulindac/pharmacology , Zebrafish Proteins , Adenoma/physiopathology , Adenomatous Polyposis Coli/physiopathology , Adult , Cell Nucleus , Chemoprevention , Colorectal Neoplasms/physiopathology , Cytoskeletal Proteins , Female , Humans , Mitogens , Signal Transduction , Trans-Activators , Transcription, Genetic , Tumor Cells, Cultured , Wnt Proteins , beta Catenin
6.
Am J Respir Cell Mol Biol ; 23(4): 560-5, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11017923

ABSTRACT

Genes of the myc family are frequently overexpressed in lung cancer. Gene amplification can explain the deregulation of these genes in a subset of tumors and cell lines, but in most cases, the cause of the elevated myc expression remains unknown. We examined whether messenger RNA (mRNA) stabilization could be contributing to myc gene overexpression in lung cancer cell lines. The decay pattern of c-myc or N-myc mRNA was analyzed in 11 such cell lines and in unimmortalized human embryonic lung cells. Eight lung cancer cell lines showed stabilization of c-myc or N-myc transcripts. To determine whether this stabilization was unique to myc genes, the decay pattern of the unstable c-fos proto-oncogene mRNA was also studied. The same cell lines that exhibited stabilization of myc mRNA showed an abnormally slow decay of the c-fos message, suggesting that there might be a correlation between the abnormal decay of c-fos and myc transcripts. In contrast, the half-life of histone 2B mRNA, which is degraded in a cell cycle-specific manner, did not appear to correlate with that of myc and fos. Our results suggest that an mRNA decay pathway responsible for the destruction of unstable proto-oncogene mRNAs may be commonly affected in lung cancers.


Subject(s)
Gene Expression Regulation, Neoplastic , Genes, myc , Lung Neoplasms/genetics , RNA Processing, Post-Transcriptional , Blotting, Northern , Half-Life , Humans , Proto-Oncogene Mas , RNA, Messenger/genetics , Tumor Cells, Cultured
7.
EMBO J ; 18(9): 2394-400, 1999 May 04.
Article in English | MEDLINE | ID: mdl-10228154

ABSTRACT

Autosomal recessive and dominant nephrogenic diabetes insipidus (NDI), a disease in which the kidney is unable to concentrate urine in response to vasopressin, are caused by mutations in the aquaporin-2 (AQP2) gene. Missense AQP2 proteins in recessive NDI have been shown to be retarded in the endoplasmic reticulum, whereas AQP2-E258K, an AQP2 mutant in dominant NDI, was retained in the Golgi complex. In this study, we identified the molecular mechanisms underlying recessive and dominant NDI. Sucrose gradient centrifugation of rat and human kidney proteins and subsequent immunoblotting revealed that AQP2 forms homotetramers. When expressed in oocytes, wild-type AQP2 and AQP2-E258K also formed homotetramers, whereas AQP2-R187C, a mutant in recessive NDI, was expressed as a monomer. Upon co-injection, AQP2-E258K, but not AQP2-R187C, was able to heterotetramerize with wild-type AQP2. Since an AQP monomer is the functional unit and AQP2-E258K is a functional but misrouted water channel, heterotetramerization of AQP2-E258K with wild-type AQP2 and inhibition of further routing of this complex to the plasma membrane is the cause of dominant NDI. This case of NDI is the first example of a dominant disease in which the 'loss-of-function' phenotype is caused by an impaired routing rather than impaired function of the wild-type protein.


Subject(s)
Aquaporins/genetics , Diabetes Insipidus, Nephrogenic/genetics , Mutation , Animals , Aquaporin 2 , Aquaporin 6 , Aquaporins/antagonists & inhibitors , Aquaporins/metabolism , Diabetes Insipidus, Nephrogenic/metabolism , Humans , Models, Biological , Oocytes , Protein Conformation , Recombinant Proteins/metabolism , Water/metabolism , Xenopus laevis
8.
Cancer Res ; 57(19): 4384-92, 1997 Oct 01.
Article in English | MEDLINE | ID: mdl-9331102

ABSTRACT

Patients with xeroderma pigmentosum (XP), a DNA repair disorder, run a large risk of developing skin cancer in sun-exposed areas. Cancer proneness in these patients correlates with a mammalian SOS-like response, "enhanced reactivation (ER) of viruses." Here, we report that radiation-induced activation of the ornithine decarboxylase (ODC) gene, a putative proto-oncogene, is required for this response. Various diploid fibroblast strains derived from a non-cancer-prone subclass of XP patients, which lack the ER response, were irradiated with 2 J/m2 and assessed for gene induction. In these fibroblasts, an absence of induction of ODC by UV-C was observed at the levels of mRNA, protein, and enzyme activity. This lack of induction is quite specific because the genes for fos and collagenase were induced as they were in normal XP cells. The apparent linkage between non-cancer proneness and a lack of ER and ODC induction was confirmed in a fibroblast strain derived from a patient with another DNA repair disorder, trichothiodystrophy, which does not lead to cancer proneness: in these cells, no induction of the ER response nor of ODC occurs after UV-C irradiation. Repair deficiency, however, is not essential because the simultaneous lack of ODC and ER induction after 10 J/m2 UV-C was found in at least one repair-proficient fibroblast. Next, a specific inhibitor of ODC, difluoromethylornithine, at a dose of 10 mM, completely blocked the ER response in cultured normal skin fibroblasts, suggesting that the ODC enzyme is in fact essential for the ER response. Difluoromethylornithine, although it did not affect other processes such as DNA repair, leads to a block in the cell division cycle at the G1-S transition. Interestingly, other blockers of this transition, wortmannin (500 nM) and mimosine (100 mM), also decreased the ER response. Finally, the ER and ODC responses also seem to be linked after treatment with X-irradiation (3 Gy), suggesting that both are part of a general response to DNA damage, at least in human skin fibroblasts. Apart from the abnormal ER and ODC responses, fibroblasts from non-tumor-prone XP patients react in the same way to radiation as do fibroblasts from tumor-prone XP patients with respect to other parameters. Thus, the lack of ODC induction after radiation may help to protect XP patients against skin carcinogenesis.


Subject(s)
Cocarcinogenesis , Ornithine Decarboxylase/physiology , Simplexvirus/physiology , Skin Neoplasms/etiology , Virus Activation/radiation effects , Xeroderma Pigmentosum/enzymology , Cell Cycle , Cell Line, Transformed , Cells, Cultured , DNA Repair , Enzyme Induction/radiation effects , Fibroblasts/enzymology , Fibroblasts/radiation effects , Fibroblasts/virology , Humans , Immunity, Innate , Male , Ornithine Decarboxylase/biosynthesis , Ornithine Decarboxylase/deficiency , Proto-Oncogene Mas , Transcription, Genetic/radiation effects , Ultraviolet Rays , Virus Activation/physiology , X-Rays , Xeroderma Pigmentosum/classification , Xeroderma Pigmentosum/complications , Xeroderma Pigmentosum/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...